AQP4 and diabetes mellitus: Collectively, our data suggest that DM-induced microthrombosis and microvascular disruption events became evident at a more advanced stage of DM (3 months after NTM-STZ injection), which was accompanied by a loss in peri-vascular AQP4 and beta-amyloid accumulation.